{
    "clinical_study": {
        "@rank": "149741", 
        "arm_group": {
            "arm_group_label": "BT injection", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The aim of this prospective non-randomized study was to assess the efficacy and safety of\n      endomyocardial botulinum toxin injection in projections of main ganglionated plexuses of\n      left atrium for preventing drug-resistant paroxysmal atrial fibrillation."
        }, 
        "brief_title": "Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Paroxysmal Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  drug-resistant PAF\n\n        Exclusion Criteria:\n\n          -  Previous heart surgery and AF ablation procedure\n\n          -  Emergency CABG\n\n          -  Unstable angina or heart failure\n\n          -  Persistent AF, AF at the time of screening (planned Maze procedure or pulmonary vein\n             isolation)\n\n          -  Use of I or III antiarrhythmic drugs within 5 elimination half-lives of the drug (or\n             within 2 months for amiodarone)\n\n          -  Requiring concomitant valve surgery\n\n          -  Left ventricle ejection fraction <35%\n\n          -  Left atrial diameter >55 mm\n\n          -  Unwillingness to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02002988", 
            "org_study_id": "BT_PAF01"
        }, 
        "intervention": {
            "arm_group_label": "BT injection", 
            "intervention_name": "endomyocardial BT injection", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Botulinum Toxins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 2, 2013", 
        "link": {
            "description": "State Research Institute of Circulation Pathology Official Site", 
            "url": "http://meshalkin.ru"
        }, 
        "location": {
            "contact": {
                "last_name": "Evgeny Pokushalov, MD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Novosibirsk", 
                    "country": "Russian Federation", 
                    "zip": "630055"
                }, 
                "name": "State Research Institute of Circulation Pathology"
            }, 
            "investigator": [
                {
                    "last_name": "Evgeny Pokushalov, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Alexander Romanov, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Artem Strelnikov, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "1", 
        "official_title": "Endomyocardial Botulinum Toxin Injection Can Prevent Drug-Resistant Paroxysmal Atrial Fibrillation: Pilot Study", 
        "overall_contact": {
            "email": "e.pokushalov@gmail.com", 
            "last_name": "Evgeny Pokushalov, MD, PhD, FESC", 
            "phone": "+79139254858"
        }, 
        "overall_official": {
            "affiliation": "State Research Institute of Circulation Pathology", 
            "last_name": "Evgeny Pokushalov, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "serious adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02002988"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "number of paroxysms", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Meshalkin Research Institute of Pathology of Circulation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meshalkin Research Institute of Pathology of Circulation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}